Skip to content

Roivant Sciences ROIV Cash Flow Statement

Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24
-$313.7M-366%-$166.04M+40.7%-$223.36M-334%-$252.38M
$638K-55.2%$691K-76.3%$921K-81.0%$1.1M-77.5%$1.43M-72.7%
$77.17M-7.6%$105M+25.5%$81.82M+14.2%$82.18M+63.7%$83.49M+78.7%
-$163.82M+5.1%-$196.48M+5.2%-$185.66M+30.4%-$204.38M-6.0%-$172.57M-59.1%
$1.26M+55.5%$7.85M+688%$4.04M+318%$811K+132%
-$1.09B-112,409%
$208.29M-67.9%$295.45M
$328.19M+220%-$187.77M+71.6%-$177.15M
-$57.79M-$1.45M+100.0%-$1.48B-72.3%
-$165.08M+4.8%-$191.55M+8.4%-$193.51M+27.7%-$208.42M-7.5%-$173.38M-59.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Roivant Sciences generate?
Roivant Sciences (ROIV) generated -$750.3M in operating cash flow over the trailing twelve months.
What is Roivant Sciences's free cash flow?
After $14.0M of capital expenditures, Roivant Sciences's free cash flow was -$758.6M over the trailing twelve months, up 10.1% year over year.
Where does Roivant Sciences's cash flow data come from?
Every line is extracted from Roivant Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.